Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5802)	10/23/1998 12:58:00 PM
From: Vector1	Read Replies (1) \| Respond to of 9719

Rman, Here is my thinking on the covered calls. First I am a major AGPH bull. They have excellent management and hold the record for pushing a drug (Viracept) through clinicals to approval. Viracept is the class of the PI's and will continue to gain market share from Crixivan. Moreover, Viracept appears to act synergystically with Sustiva and IMO the gold standard wil be a four drug regime including Viracept for some time. Ok why do I want to sell covered calls. I believe the stock will trade in a range of 33 -43 throught he end of the year. If the stock hits $40 over the next week or so the November 45s should trade at $1 1/2 to 2. I see it as free money because if the stock climbs to 47 in that time frame I would sell anyway. V1